Risk Factors and Mortality Among Women With Interval Breast Cancer vs Screen-Detected Breast Cancer

被引:2
|
作者
Song, Huiyeon [1 ]
Tran, Thi Xuan Mai [1 ]
Kim, Soyeoun [2 ]
Park, Boyoung [1 ,3 ]
机构
[1] Hanyang Univ, Coll Med, Dept Prevent Med, 222 Wangsimni Ro, Seoul 04763, South Korea
[2] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea
[3] Hanyang Univ, Hanyang Inst Biosci & Biotechnol, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
TUMOR CHARACTERISTICS; MAMMOGRAPHIC DETECTION; PROGRAM; FILM;
D O I
10.1001/jamanetworkopen.2024.11927
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE The risk factors for interval breast cancer (IBC) compared with those for screen-detected breast cancer (SBC) and their association with mortality outcomes have not yet been evaluated among Korean women. OBJECTIVE To evaluate risk factors associated with IBC and survival among Korean women with IBC compared with those with SBC. DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort study used data from the Korean National Health Insurance Service Database. Women who participated in a national mammographic breast cancer screening program between January 1, 2009, and December 31, 2012, were included. Mortality outcomes were calculated from the date of breast cancer diagnosis to the date of death or December 31, 2020. Data were analyzed from March 1 to June 30, 2023. EXPOSURE Breast cancer diagnosed within 6 to 24 months after a negative screening result (ie, IBC) or within 6 months after a positive screening result (ie, SBC). MAIN OUTCOMES AND MEASURES Risk factors and survival rates for IBC and SBC. RESULTS This study included 8702 women with IBC (mean [SD] age, 53.3 [8.6] years) and 9492 women with SBC (mean [SD] age, 54.1 [9.0] years). Compared with SBC, the probability of IBC decreased as mammographic density increased. Lower body mass index, menopausal status, hormone replacement therapy (HRT) use, and lack of family history of breast cancer were associated with a higher likelihood of IBC. When stratified by detection time, younger age at breast cancer diagnosis and family history of breast cancer were associated with an increased likelihood of IBC diagnosed at 6 to 12 months but a decreased likelihood of IBC diagnosed at 12 to 24 months. Overall mortality of IBC was comparable with SBC, but total mortality and cancer-related mortality of IBC diagnosed between 6 and 12 months was higher than that of SBC. CONCLUSIONS AND RELEVANCE The findings of this cohort study suggest that breast density, obesity, and HRT use were associated with IBC compared with SBC. These findings also suggest that higher supplemental breast ultrasound use among Korean women, especially those with dense breasts, could be attributed to a lower incidence of IBC among women with dense breasts compared with women with SBC, due to greater detection. Finally, overall mortality of IBC was comparable with that of SBC.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Does preoperative axillary staging lead to overtreatment of women with screen-detected breast cancer?
    Wallis, M. G.
    Kilburn-Toppin, F.
    Taylor-Phillips, S.
    CLINICAL RADIOLOGY, 2018, 73 (05) : 467 - 472
  • [42] TREATMENT OF THE AXILLA IN PATIENTS WITH SCREEN-DETECTED BREAST-CANCER
    WALLS, J
    BOGGIS, CRM
    WILSON, M
    ASBURY, DL
    ROBERTS, JV
    BUNDRED, NJ
    MANSEL, RE
    BRITISH JOURNAL OF SURGERY, 1993, 80 (04) : 436 - 438
  • [43] Interval Breast Cancer Versus Screen-Detected Cancer: Comparison of Clinicopathologic Characteristics in a Single-Center Analysis
    Bellio, Gabriele
    Marion, Riccardo
    Giudici, Fabiola
    Kus, Sara
    Tonutti, Maura
    Zanconati, Fabrizio
    Bortul, Marina
    CLINICAL BREAST CANCER, 2017, 17 (07) : 564 - 571
  • [44] Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancer
    Strand, Fredrik
    Humphreys, Keith
    Eriksson, Mikael
    Li, Jingmei
    Andersson, Therese M. L.
    Tornberg, Sven
    Azavedo, Edward
    Shepherd, John
    Hall, Per
    Czene, Kamila
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (01) : 34 - 40
  • [45] Breast Cancer Characteristics Associated With Digital Versus Film-Screen Mammography for Screen-Detected and Interval Cancers
    Henderson, Louise M.
    Miglioretti, Diana L.
    Kerlikowske, Karla
    Wernli, Karen J.
    Sprague, Brian L.
    Lehman, Constance D.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2015, 205 (03) : 676 - 684
  • [46] The Role of Preoperative Magnetic Resonance Imaging in the Assessment and Surgical Treatment of Interval and Screen-Detected Breast Cancer in Older Women
    Goodrich, Martha E.
    Weiss, Julie
    Onega, Tracy
    Balch, Steve L.
    Buist, Diana S. M.
    Kerlikowske, Karla
    Henderson, Louise M.
    Hubbard, Rebecca A.
    BREAST JOURNAL, 2016, 22 (06): : 616 - 622
  • [47] Genetic landscape of interval and screen detected breast cancer
    Mills, Charlie
    Sud, Amit
    Everall, Andrew
    Chubb, Daniel
    Lawrence, Samuel E. D.
    Kinnersley, Ben
    Cornish, Alex J.
    Bentham, Robert
    Houlston, Richard S.
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [48] Tumour characteristics of screen-detected and interval cancers in the Flemish Breast Cancer Screening Programme: A mammographic breast density study
    Timmermans, Lore
    De Brabander, Isabel
    Van Damme, Nancy
    Bleyen, Luc
    Martens, Patrick
    Van Herck, Koen
    Thierens, Hubert
    Bacher, Klaus
    Depypere, Herman
    MATURITAS, 2022, 158 : 55 - 60
  • [49] Screen-detected versus interval cancers: Effect of imaging modality and breast density in the Flemish Breast Cancer Screening Programme
    Timmermans, Lore
    Bleyen, Luc
    Bacher, Klaus
    Van Herck, Koen
    Lemmens, Kim
    Van Ongeval, Chantal
    Van Steen, Andre
    Martens, Patrick
    De Brabander, Isabel
    Goossens, Mathieu
    Thierens, Hubert
    EUROPEAN RADIOLOGY, 2017, 27 (09) : 3810 - 3819
  • [50] Survival of women with screen detected breast cancer
    Wheeler, E
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S138 - S138